adenine has been researched along with Hyponatremia in 1 studies
Hyponatremia: Deficiency of sodium in the blood; salt depletion. (Dorland, 27th ed)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rogers, KA | 1 |
| Huang, Y | 1 |
| Ruppert, AS | 1 |
| Abruzzo, LV | 1 |
| Andersen, BL | 1 |
| Awan, FT | 1 |
| Bhat, SA | 1 |
| Dean, A | 1 |
| Lucas, M | 1 |
| Banks, C | 1 |
| Grantier, C | 1 |
| Heerema, NA | 1 |
| Lozanski, G | 1 |
| Maddocks, KJ | 1 |
| Valentine, TR | 1 |
| Weiss, DM | 1 |
| Jones, JA | 1 |
| Woyach, JA | 1 |
| Byrd, JC | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Obinutuzumab, Ibrutinib, and Venetoclax for Relapsed and Previously Untreated Chronic Lymphocytic Leukemia (CLL)[NCT02427451] | Phase 1/Phase 2 | 87 participants (Actual) | Interventional | 2015-08-03 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for adenine and Hyponatremia
| Article | Year |
|---|---|
Phase II Study of Combination Obinutuzumab, Ibrutinib, and Venetoclax in Treatment-Naïve and Relapsed or Refractory Chronic Lymphocytic Leukemia.
Topics: Adenine; Adult; Aged; Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protoc | 2020 |